Chronic Heart Failure
Research reports from Osaka University, Department of Cardiovascular Medicine provide new insights into chronic heart failure
Published in Drug Law Weekly, December 18th, 2007
Data detailed in 'Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study' have been presented. According to a study from Suita, Japan, "Adenosine is known as an endogenous cardioprotectant. We previously reported that plasma adenosine levels increase in patients with chronic heart failure (CHF), and that a treatment that further elevates plasma adenosine levels may improve the pathophysiology of CHF."
"Therefore, we performed a prospective, open-randomized clinical trial to determine whether or not exposure to dipyridamole for 1 year improves CHF...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-12-18)
More Articles from Drug Law Weekly
- America's Second Harvest
Appropriations Veto Threats May Lead to Further Hardship for Hungry Americans - Bioinformatics
Eclipsys Chief Medical Officer Bob Elson, MD, to Present on Value of e-Prescribing at Capitol Hill Briefing - Biomedicine
California Healthcare Institute Urges Congress to Extend R&D Tax Credit - Biotechnology Business
Biovail Announces Settlement Agreement Related to Cardizem(R) LA - Biotechnology Business
David Luci Joins MacroChem as General Counsel and Vice President Corporate Development - Biotechnology Business
Watson and Biovail Settle Lawsuit Over Cardizem(R) LA - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
